Emergent BioSolutions Inc. (EBS) Earnings History
Annual and quarterly earnings data from 2001 to 2025
Loading earnings history...
EBS EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
EBS Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 47.2% | 14.8% | 7.1% |
| 2024 | 36.0% | -10.4% | -18.3% |
| 2023 | 34.3% | -69.2% | -72.5% |
| 2022 | 42.3% | -15.2% | -18.9% |
| 2021 | 44.7% | 19.2% | 12.4% |
Download Data
Export EBS earnings history in CSV or JSON format
Free sign-in required to download data
Emergent BioSolutions Inc. (EBS) Earnings Overview
As of May 8, 2026, Emergent BioSolutions Inc. (EBS) reported trailing twelve-month net income of $53M, reflecting +125.8% year-over-year growth. The company earned $1.00 per diluted share over the past four quarters, with a net profit margin of 7.1%.
Looking at the long-term picture, EBS's 5-year EPS compound annual growth rate (CAGR) stands at -30.3%, signaling declining earnings. The company achieved its highest annual net income of $306M in fiscal 2020.
Emergent BioSolutions Inc. maintains positive profitability with a gross margin of 47.2%, operating margin of 14.8%, and net margin of 7.1%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including SIGA (-$4.04T net income, 24.6% margin), PRGO (-$1.82B net income, -33.5% margin), BRKR (-$12M net income, -0.3% margin), EBS has room to improve margins relative to the peer group. Compare EBS vs SIGA →
EBS Earnings vs Peers
Earnings metrics vs comparable public companies
EBS Historical Earnings Data (2001–2025)
23 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $53M | +127.6% | $110M | $0.93 | 7.1% | 14.8% |
| 2024 | -$191M | +74.9% | -$109M | $-3.60 | -18.3% | -10.4% |
| 2023 | -$761M | -259.4% | -$726M | $-14.85 | -72.5% | -69.2% |
| 2022 | -$212M | -196.4% | -$170M | $-4.22 | -18.9% | -15.2% |
| 2021 | $220M | -28.2% | $341M | $4.06 | 12.4% | 19.2% |
| 2020 | $306M | +461.1% | $439M | $5.67 | 19.4% | 27.8% |
| 2019 | $55M | -13.1% | $114M | $1.04 | 4.9% | 10.3% |
| 2018 | $63M | -24.1% | $90M | $1.22 | 8.0% | 11.5% |
| 2017 | $83M | +59.5% | $124M | $1.71 | 14.7% | 22.2% |
| 2016 | $52M | -17.6% | $106M | $1.13 | 10.6% | 21.6% |
See EBS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs EBS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare EBS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonEBS — Frequently Asked Questions
Quick answers to the most common questions about buying EBS stock.
Is EBS growing earnings?
EBS EPS is $1.00, with earnings growth accelerating to +125.8%. This exceeds the 5-year CAGR of -30.3%. TTM net income reached $53M.
What are EBS's profit margins?
Emergent BioSolutions Inc. net margin is +7.1%, with operating margin at +14.8%. Margins sit within typical range for the sector.
How consistent are EBS's earnings?
EBS earnings data spans 2001-2025. The accelerating earnings trend is +125.8% YoY. Historical data enables comparison across business cycles.